50 million Americans due for colon cancer screening avoid it because they consider traditional tests so unpleasant. But now it can be as simple as a blood test. If you’re overdue for your ...

Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has Option to Commercialize Test Kit Assuming FDA ApprovalBERKELEY ...

Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal cancer screening test, ColoAlert. The test leverages polymerase chain ...

Mainz Biomed’s stool-based ColoAlert test is designed to detect colorectal cancer tumor ... Services Task Force recommends that screening with stool DNA-FIT (sDNA-FIT) tests should be conducted ...

Bowel cancer screening using a home kit called a faecal immunochemical test (FIT) is currently available for those aged 54 to ...

(DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert test. The stool-based test, utilizing polymerase chain reaction technology, detects colorectal ...

Colorectal cancer is the third-most common type of cancer around the world. In the earlier stages, it can be tough to catch. The symptoms, like diarrhea, abdominal pain and anemia, can easily be ...